Skye Bioscience SKYE
NASDAQ SKYE
$1.59 -0.02 (-1.24%)
At close: Sep 29, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Non-Current Assets (2012 - 2026)

Updated

Skye Bioscience (SKYE) posted Non-Current Assets of $74,908 for Q2 2026, down 95.3% from $1.58 million a year earlier and down 91.2% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Non-Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2025, Skye Bioscience's Non-Current Assets came in at $1.22 million, down 37.0% from FY2024.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 178.0% (FY2020 to FY2025).
  • In prior years, Skye Bioscience's Non-Current Assets was $1.94 million in FY2024 (+568.8%), $289,568 in FY2023 (+73.0%), $167,354 in FY2022 (-31.1%) and $242,991 in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q2 2021.
  • On a year-over-year basis, Non-Current Assets has declined in each of the last four quarters, with growth averaging 236.0% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2022, with growth of 889.3%; the weakest was Q2 2026, with a decline of 95.3%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $849,767 (Q1 2026), $1.22 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Skye Bioscience 7.07 Mn 7.07 Mn - 74,908.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74,908.00
Mar 31, 2026 849,767.00
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.77 Mn
Dec 31, 2024 1.94 Mn
Sep 30, 2024 1.73 Mn
Jun 30, 2024 257,068.00
Mar 31, 2024 265,189.00
Dec 31, 2023 289,568.00
Sep 30, 2023 318,141.00
Jun 30, 2023 343,257.00
Mar 31, 2023 136,040.00
Dec 31, 2022 167,354.00
Sep 30, 2022 185,536.00
Jun 30, 2022 193,542.00
Mar 31, 2022 218,012.00
Dec 31, 2021 242,991.00
Sep 30, 2021 253,279.00
API Access

Skye Bioscience Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY